ChAdOx1 nCoV-19/AZD1222 is an approved adenovirus-based vaccine for severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) currently being deployed globally. Previous …

Intramuscular vaccination with ChAdOx1 nCoV-19/AZD1222 protected rhesus macaques
against pneumonia but did not reduce shedding of SARS-CoV-2. Here we investigate whether …

Animal host–microbe interactions are a relevant concern for wildlife conservation, particularly
regarding generalist pathogens, where domestic host species can play a role in the …

Coronavirus disease 2019 (COVID-19) is known to cause multi-organ dysfunction 1 , 2 – 3
during acute infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), …

Effective therapies to treat coronavirus disease 2019 (COVID-19) are urgently needed. While
many investigational, approved, and repurposed drugs have been suggested as potential …

Middle East respiratory syndrome coronavirus (MERS-CoV) infects humans and dromedary
camels and is responsible for an ongoing outbreak of severe respiratory illness in humans in …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA is frequently detected
in the feces of infected individuals. While infectious SARS-CoV-2 has not previously been …

In the past two decades, three coronaviruses with ancestral origins in bats have emerged
and caused widespread outbreaks in humans, including severe acute respiratory syndrome …

Rotaviruses (RVs) are classified into eight species/groups (RVA–RVH) according to the
migration patterns of their 11 genome segments, as well as by serological and molecular …

Ambient temperature and humidity strongly affect inactivation rates of enveloped viruses,
but a mechanistic, quantitative theory of these effects has been elusive. We measure the …